Publication | Closed Access

Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas

InflammationCell TherapyImmunologyImmunomodulationCell BiologyImmunotherapyMedicineCell TransplantationTumor MicroenvironmentIntratumoral InjectionDendritic Cells